Antares Pharma, Inc. (ATRS)

Long-Term Debt

$22.95M

Quarterly · Period ending: · USD

ATRS logo

ATRS Long-Term Debt

Latest reported$22.95M
ATRS Quarterly Long-Term Debt ($100.00K → $22.95M)
High-resolution chart · PNG

ATRS long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
22,954,000
19,741,000
23,014,000
7,890,000
19,362,000
24,669,000
34,358,000
40,647,000
40,521,000
40,395,000
40,269,000
40,143,000
20,260,000
22,083,000
25,059,000
24,992,000
24,925,000
24,858,000
24,791,214
24,724,304
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,818
845,693
1,548,337
2,239,550
2,899,727
3,569,988
4,084,480
4,665,467
3,334,093
4,065,449
3,960,628
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,230
70,975
58,168
38,651
44,566
48,774
51,474
54,094
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.